Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Shares Issued (2016 - 2023)

Marimed (MRMD) has disclosed Shares Issued for 7 consecutive years, with $74000.0 as the latest value for Q3 2023.

  • On a quarterly basis, Shares Issued changed N/A to $74000.0 in Q3 2023 year-over-year; TTM through Dec 2024 was $74000.0, a 32.11% decrease, with the full-year FY2023 number at $109000.0, up 990.0% from a year prior.
  • Shares Issued was $74000.0 for Q3 2023 at Marimed, up from $35000.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $2.1 million in Q4 2019 to a low of $3000.0 in Q1 2022.
  • A 4-year average of $294444.8 and a median of $33500.0 in 2021 define the central range for Shares Issued.
  • Peak YoY movement for Shares Issued: plummeted 93.24% in 2019, then plummeted 62.5% in 2022.
  • Marimed's Shares Issued stood at $2.1 million in 2019, then plummeted by 98.5% to $32000.0 in 2021, then crashed by 90.62% to $3000.0 in 2022, then soared by 2366.67% to $74000.0 in 2023.
  • Per Business Quant, the three most recent readings for MRMD's Shares Issued are $74000.0 (Q3 2023), $35000.0 (Q2 2023), and $3000.0 (Q1 2022).